West Africa Launches Plan for Lassa Fever Vaccine Access

West Africa is taking charge of its health future with a groundbreaking plan to make Lassa fever vaccines accessible to everyone who needs them.

The West African Health Organisation launched the Lassa Fever End-to-End Access Roadmap in Abidjan, Côte d'Ivoire, this February. This first-of-its-kind framework guides countries through every step needed to move vaccines from laboratory development all the way to sustained public use.

The timing couldn't be more critical. Lassa fever kills thousands of West Africans every year and overwhelms already stretched health systems. Nigeria alone recorded 21 new cases and nine deaths in just the first week of 2026, with a case fatality rate of nearly 43 percent.

The disease spreads through contact with food or household items contaminated by infected rats, and can also pass between people through bodily fluids. It starts with fever, weakness, and headaches but can progress to bleeding, breathing problems, and organ failure.

Hope is building as vaccine development accelerates. A candidate vaccine from the University of Oxford entered its first human trials in the United Kingdom in January, with larger African trials expected to include Nigeria soon. Experts predict the first vaccine approvals could come within five years.

But Emma Wheatley from the Coalition for Epidemic Preparedness Innovations knows that scientific breakthroughs alone won't save lives. "For decades, Lassa fever has affected the lives and livelihoods of people across West Africa, but the tide is turning," she said. "We must begin our preparations for what's to come now."

The roadmap covers everything from research and manufacturing to financing, delivery systems, and long-term sustainability. By mapping out responsibilities, timelines, and decision points, it helps governments, manufacturers, funders, and partners work together seamlessly.

What makes this framework special is that West Africans designed it themselves. The roadmap emerged from extensive consultations with national governments, regional bodies, technical experts, civil society groups, manufacturers, and global health partners.

The Ripple Effect

This isn't just about one vaccine. The roadmap creates a model for how regions can take ownership of their health priorities and ensure equitable access to lifesaving tools. By starting preparations years before approval, West Africa is flipping the script on vaccine access that has historically favored wealthy nations.

The framework puts endemic countries at the center of planning, ensuring that vaccines will be affordable and accessible where they're needed most. Strong regional coordination through WAHO means countries can align their efforts and share resources effectively.

Dr. Virgil Lokossou, Director of Healthcare Services at WAHO, captured the significance perfectly: "The roadmap represents a decisive step forward, a clear, region-led framework through which West Africa is defining its own priorities for vaccine access."

When those vaccines finally arrive, West Africa will be ready to protect its people.